08.06.2020
- With national governments racing to nail down doses of a Covid-19 vaccine – when it comes – for their own populations, the EU’s leadership is keen to make sure that its own...
05.06.2020
- Gilead Sciences has entered a 10-year partnership with oncology-focused biopharma Arcus Biosciences to develop and commercialize current and future therapeutic candidates in Arcus...
05.06.2020
- GlaxoSmithKline (GSK) has agreed to make 1 billion doses of its AS03 adjuvant available to several developers of Covid-19 vaccines and plans to increase capacity to supply enough...
03.06.2020
- Novartis's gene therapy unit AveXis has signed an agreement to produce a novel genetic COVID-19 vaccine being developed by the US-based Mass General Brigham health care system...
01.06.2020
- German Contract Development & Manufacturing Organization CordenPharma has expanded its strategic manufacturing services agreement with Moderna to include the supply of lipid...
28.05.2020
- US pharma giant Merck & Co is wading into the race to find a vaccine or treatment for Covid-19. The New Jersey-based company is joining forces with nonprofit research group IAVI on...
22.05.2020
- Roche has signed a worldwide option and license agreement with Vividion Therapeutics, gaining access to the latter’s proteomics screening platform and proprietary small molecule...
22.05.2020
- The US Biomedical Advanced Research and Development Authority (BARDA) has added another illustrious European pharmaceutical industry player to the list of those whose resources it...
18.05.2020
- Achieve business excellence with end-to-end scientific collaboration platform for faster drug-to-market & agile medical device manufacturing. Join us for our webinar series to...
Former head of GlaxoSmithKline's (GSK) vaccines division, Moncef Slaoui, has been named to lead the so-called "warp speed" effort to develop a coronavirus vaccine...
